trial

SEEG-Guided DBS for Schizophrenia

NCTId NCT07671261
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 46 (estimated)
Sponsored by Ruijin Hospital
Primary completion 2028-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
46 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2025-08-17
Primary completion
2028-12-31
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
SEEG implantationDeep brain stimulation

Sponsors

Ruijin HospitalLead Sponsor

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
46
Phase
NA
Primary Completion Date
2028-12-31
Status
RECRUITING
relationships
The graph out of here
drug
SEEG implantation
drug
Deep brain stimulation
drug
lead_sponsor
Ruijin Hospital
company
indication
Schizo Affective Disorder
indication
Schizophrenia Disorders
indication
Schizophrenia
indication